In referring to the AGM presentation, specifically the Research to Development table from FY09 - FY12.
I notice that unlike the 2011 AGM presentation, there is no mention of the UK FMCG company which was the company behind the Azopharma funded testing. Big shame. They havent been mentioned at all for a while from my recollections.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable